| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1046/J.1440-1681.1999.03049.X |
| P8608 | Fatcat ID | release_3k5c4rlmcff63mkdhhj3a5ncqu |
| P698 | PubMed publication ID | 10405772 |
| P50 | author | Mark A. Connor | Q44336221 |
| P2093 | author name string | M D Christie | |
| P2860 | cites work | mu and delta opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells | Q44339787 |
| Opioid receptors in magnesium-digitonin-solubilized rat brain membranes are tightly coupled to a pertussis toxin-sensitive guanine nucleotide-binding protein | Q44339867 | ||
| The GTP-binding protein, Go, regulates neuronal calcium channels | Q44508440 | ||
| The elusive nature of intrinsic efficacy | Q47689706 | ||
| How opioids inhibit GABA-mediated neurotransmission | Q48580369 | ||
| Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. | Q55063215 | ||
| The orphan opioid receptor and its endogenous ligand — nociceptin/orphanin FQ | Q56591848 | ||
| The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange | Q24310009 | ||
| Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor | Q24311708 | ||
| G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C | Q24324791 | ||
| Purification, molecular cloning, and expression of the mammalian sigma1-binding site | Q24619317 | ||
| Cloning of a delta opioid receptor by functional expression | Q28213132 | ||
| Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids | Q28306785 | ||
| Cloning and functional comparison of kappa and delta opioid receptors from mouse brain | Q28378630 | ||
| Multiple neurological abnormalities in mice deficient in the G protein Go | Q28585725 | ||
| Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast | Q28587451 | ||
| Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I | Q28645568 | ||
| Gz-mediated hormonal inhibition of cyclic AMP accumulation | Q28646144 | ||
| The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization | Q30800519 | ||
| Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP | Q33979467 | ||
| Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins | Q34306079 | ||
| Specificity of opioids towards the μ-, δ- and ϵ-opiate receptors | Q34309814 | ||
| G protein beta gamma subunits. | Q34424307 | ||
| Endogenous opioid peptides: multiple agonists and receptors | Q34986433 | ||
| Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits | Q34993267 | ||
| Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells | Q36213932 | ||
| Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain | Q36279301 | ||
| Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness | Q36514037 | ||
| Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain | Q36726539 | ||
| Block of calcium channels by enkephalin and somatostatin in neuroblastoma-glioma hybrid NG108-15 cells | Q37413178 | ||
| Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2 | Q38341212 | ||
| GX/Z Is Regulated by μ But Not δ Opioid Receptors in the Stimulation of the Low Km GTPase Activity in Mouse Periaqueductal Grey Matter | Q38345403 | ||
| Rat vas deferens: a specific bioassay for endogenous opioid peptides | Q40062762 | ||
| Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence | Q41247864 | ||
| Inhibition of the omega-conotoxin-sensitive calcium current by distinct G proteins | Q41632988 | ||
| Differential regulation of amounts of the guanine-nucleotide-binding proteins Gi and Go in neuroblastoma x glioma hybrid cells in response to dibutyryl cyclic AMP | Q42120332 | ||
| Mu-opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium-channel opening. | Q42165827 | ||
| Properties of a kappa-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual G alpha subunit and is similar to that of other opioid receptors | Q44333677 | ||
| Gz coupling to the rat kappa-opioid receptor | Q44336007 | ||
| P433 | issue | 7 | |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 493-499 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Clinical and Experimental Pharmacology and Physiology | Q5133807 |
| P1476 | title | Opioid receptor signalling mechanisms | |
| P478 | volume | 26 |
| Q43102765 | A New Method for Radiosynthesis of C-Labeled Carbamate Groups and its Application for a Highly Efficient Synthesis of the Kappa-Opioid Receptor Tracer [C]GR103545. |
| Q24317131 | A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism |
| Q44343371 | A photochromic agonist for μ-opioid receptors |
| Q44340996 | A real-time, fluorescence-based assay for measuring μ-opioid receptor modulation of adenylyl cyclase activity in Chinese hamster ovary cells |
| Q88126136 | Actin filament reorganization in astrocyte networks is a key functional step in neuroinflammation resulting in persistent pain: novel findings on network restoration |
| Q90171681 | Activation of the α2B adrenoceptor by the sedative sympatholytic dexmedetomidine |
| Q38340649 | Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus |
| Q33709318 | Acute morphine alters GABAergic transmission in the central amygdala during naloxone-precipitated morphine withdrawal: role of cyclic AMP. |
| Q32027234 | Acute opioid receptor desensitization and tolerance: is there a link? |
| Q33976326 | Age-dependent effects of kappa-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study |
| Q40724494 | Agonists activate Gi1 alpha or Gi2 alpha fused to the human mu opioid receptor differently |
| Q36281799 | Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system |
| Q92104841 | Altering Opioid Neuromodulation in the Songbird Basal Ganglia Modulates Vocalizations |
| Q37258385 | Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management. |
| Q36232833 | Buprenorphine-elicited alteration of adenylate cyclase activity in human embryonic kidney 293 cells coexpressing κ-, μ-opioid and nociceptin receptors. |
| Q36741881 | Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction |
| Q34939590 | Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1) |
| Q46653217 | Clinical response to morphine in cancer patients and genetic variation in candidate genes |
| Q37386620 | Communication networks in the brain: neurons, receptors, neurotransmitters, and alcohol |
| Q44342847 | Comparison of opioid and alpha–2 adrenergic receptor binding in horse and dog brain using radioligand autoradiography |
| Q36893151 | Coupling specificity of NOP opioid receptors to pertussis-toxin-sensitive Galpha proteins in adult rat stellate ganglion neurons using small interference RNA |
| Q34659433 | Descending control of pain |
| Q89892013 | Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists |
| Q35243402 | Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors. |
| Q28364877 | Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against various Gi-protein alpha subunits |
| Q36007619 | Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray |
| Q40555581 | Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord |
| Q38845495 | Emerging Targets in Photopharmacology. |
| Q39887680 | Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control |
| Q44333083 | Evidence for transduction of mu but not kappa opioid modulation of extracellular signal-regulated kinase activity by G(z) and G(12) proteins |
| Q82085847 | Ficus deltoidea (Mas cotek) extract exerted anti-melanogenic activity by preventing tyrosinase activity in vitro and by suppressing tyrosinase gene expression in B16F1 melanoma cells |
| Q37184794 | G protein betagamma subunits as targets for small molecule therapeutic development |
| Q37167274 | G protein βγ subunits: central mediators of G protein-coupled receptor signaling |
| Q39210606 | Glial dysfunction and persistent neuropathic postsurgical pain. |
| Q38289893 | Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between |
| Q40900896 | Human neutrophils as a source of nociceptin: a novel link between pain and inflammation. |
| Q38870148 | Hyperpigmentation mechanism of methyl 3,5-di-caffeoylquinate through activation of p38 and MITF induction of tyrosinase |
| Q48154308 | Identification of central nervous system sites involved in the water diuresis response elicited by central microinjection of nociceptin/ Orphanin FQ in conscious rats via c-Fos and inducible cAMP early repressor immunocytochemistry. |
| Q36633126 | Imaging of opioid receptors in the central nervous system |
| Q28582209 | Integrins regulate opioid receptor signaling in trigeminal ganglion neurons |
| Q44006781 | MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells |
| Q24301002 | MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes |
| Q37419004 | Membrane functional organisation and dynamic of mu-opioid receptors |
| Q37718662 | Molecular assays for characterization of alternatively spliced isoforms of the u opioid receptor (MOR). |
| Q35177403 | Molecular basis of opioid dependence: role of signal regulation by G-proteins |
| Q35927616 | Mu-opioid receptor desensitization: is morphine different? |
| Q43984413 | Neuroprotective role of delta-opioid receptors in cortical neurons. |
| Q35112207 | Nociceptin/Orphanin FQ: Actions within the Brain |
| Q43916448 | Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems |
| Q34116565 | Opioid receptor and peptide gene polymorphisms: potential implications for addictions |
| Q31888173 | Opioid-induced adenylyl cyclase supersensitization in human embryonic kidney 293 cells requires pertussis toxin-sensitive G proteins other than G(i1) and G(i3). |
| Q46647198 | Opioid-induced analgesia and hyperalgesia |
| Q44807834 | Opioid-induced hyperalgesia. Pathophysiology and clinical relevance |
| Q35087640 | Opioid-mediated regulation of A11 diencephalospinal dopamine neurons: pharmacological evidence of activation by morphine |
| Q33793250 | Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling |
| Q36574138 | Panic, suffocation false alarms, separation anxiety and endogenous opioids |
| Q37314270 | Peripheral mechanisms of pain and analgesia |
| Q27317766 | Peripheral sensitization increases opioid receptor expression and activation by crotalphine in rats |
| Q37679197 | Pharmacological Profiles of Oligomerized μ-Opioid Receptors |
| Q37895053 | Possible sites of therapeutic action in restless legs syndrome: focus on dopamine and α2δ ligands |
| Q44026102 | Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO. |
| Q33643934 | Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord |
| Q41978281 | Proteomic analysis of post-nuclear supernatant fraction and percoll-purified membranes prepared from brain cortex of rats exposed to increasing doses of morphine. |
| Q41370228 | Renal responses produced by microinjection of the kappa opioid receptor agonist, U50-488H, into sites within the rat lamina terminalis |
| Q28179746 | Selective interactions between helix VIII of the human mu-opioid receptors and the C terminus of periplakin disrupt G protein activation |
| Q35077041 | Stressed to death: implication of lymphocyte apoptosis for psychoneuroimmunology |
| Q91028746 | Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex |
| Q56674183 | Structure of the µ-opioid receptor–Gi protein complex |
| Q44100463 | Sympathetic denervation-induced changes in G protein expression in enteric neurons of the guinea pig colon |
| Q96609788 | The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides |
| Q38525200 | The human delta opioid receptor activates G(i1)alpha more efficiently than G(o1)alpha. |
| Q28768058 | The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway |
| Q36840304 | The role of NOP receptors in psychomotor stimulation and locomotor sensitization induced by cocaine and amphetamine in mice |
| Q36506160 | The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment |
| Q36973386 | Ultralow Dose of Naloxone as an Adjuvant to Intrathecal Morphine Infusion Improves Perceived Quality of Sleep but Fails to Alter Persistent Pain: A Randomized, Double-blind, Controlled Study. |
| Q43295831 | Vaginocervical stimulation induces Fos in glutamate neurons in the ventromedial hypothalamus: attenuation by estrogen and progesterone |
| Q39285351 | Voltage-dependent kappa-opioid modulation of action potential waveform-elicited calcium currents in neurohypophysial terminals |
| Q30250027 | Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? |
| Q44070621 | Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain |
| Q44331698 | mu-Opioid receptors often colocalize with the substance P receptor (NK1) in the trigeminal dorsal horn. |
| Q44346717 | β-Arrestin2 influences the response to methadone in opioid-dependent patients. |
| Q37617407 | μ-Opioid inhibition of Ca2+ currents and secretion in isolated terminals of the neurohypophysis occurs via ryanodine-sensitive Ca2+ stores |
| Q35171345 | μ-Opioid receptor coupling to Gα(o) plays an important role in opioid antinociception |
Search more.